Morbid obesity increases the risk of complications and allograft failure in transplant patients. Bariatric surgery is both safe and effective in patients with chronic kidney disease and end-stage renal disease, improves eligibility for transplant based on body mass index, and does not affect postoperative immunosuppressant dosing regimens. Bariatric surgery in patients with liver disease has been shown to be safe and effective, although they remain at high risk in the setting of portal hypertension. Sleeve gastrectomy may become increasingly used both pretransplant and posttransplant, as it can result in low complication rates and excellent weight loss, and retains intestinal continuity.

Original languageEnglish (US)
Pages (from-to)1359-1371
Number of pages13
JournalSurgical Clinics of North America
Issue number6
StatePublished - Dec 2013


  • Bariatric surgery
  • Kidney transplantation
  • Liver transplantation
  • Obesity

ASJC Scopus subject areas

  • Surgery


Dive into the research topics of 'Bariatric surgery and end-stage organ failure'. Together they form a unique fingerprint.

Cite this